Singhal Priya

Track

Insider profile

Performance

Overall performance
3.5
Performance over holding periods
3.5
30 days 90 days 120 days
Average return 2% 8.2% 15.1%
Success rate 75% 68% 82%
Transactions
13 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Singhal Priya's trades of Biogen Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-02-10 2026-02-09
US Biogen Inc (BIIB)
S Sale
27,486 -45.2%
53.15
US$1,858,513 		27,486 -45.2% 53.15 US$1,858,513
2026-02-09 2026-02-09
US Biogen Inc (BIIB)
PrS Proposed sale
30,414
182.82
US$3,951,409 		30,414 182.82 US$3,951,409
2026-02-03 2026-02-02
US Biogen Inc (BIIB)
S Sale
77,110 +7.0%
187.97
US$2,417,230 		77,110 +7.0% 187.97 US$2,417,230
2026-02-03 2026-02-02
US Biogen Inc (BIIB)
S Sale
748 -10.7%
179.30
US$134,116 		748 -10.7% 179.30 US$134,116
2026-02-02 2026-02-02
US Biogen Inc (BIIB)
PrS Proposed sale
748
179.30
US$134,116 		748 179.30 US$134,116
2025-09-02 2025-09-02
US Biogen Inc (BIIB)
PrS Proposed sale
517
133.55
US$69,045 		517 133.55 US$69,045
2025-09-02 2025-09-02
US Biogen Inc (BIIB)
S Sale
517 -8.2%
133.55
US$69,045 		517 -8.2% 133.55 US$69,045
2025-05-20 2025-05-19
US Biogen Inc (BIIB)
PlS Planned sale
3,806 -41.2%
126.25
US$480,508 		3,806 -41.2% 126.25 US$480,508
2025-05-19 2025-05-19
US Biogen Inc (BIIB)
PrS Proposed sale
3,806
126.25
US$480,508 		3,806 126.25 US$480,508
2024-12-09 2024-12-09
US Biogen Inc (BIIB)
PrS Proposed sale
110
157.21
US$17,293 		110 157.21 US$17,293
2024-12-09 2024-12-09
US Biogen Inc (BIIB)
S Sale
110 -2.0%
157.21
US$17,293 		110 -2.0% 157.21 US$17,293
2024-09-05 2024-09-03
US Biogen Inc (BIIB)
S Sale
431 -7.5%
204.22
US$88,019 		431 -7.5% 204.22 US$88,019
2024-09-03 2024-09-03
US Biogen Inc (BIIB)
PrS Proposed sale
431
204.22
US$88,019 		431 204.22 US$88,019
2024-04-03 2024-04-02
US Biogen Inc (BIIB)
PlS Planned sale
93 -1.9%
213.09
US$19,817 		93 -1.9% 213.09 US$19,817
2024-04-02 2024-04-02
US Biogen Inc (BIIB)
PrS Proposed sale
93
213.09
US$19,817 		93 213.09 US$19,817
2024-02-26 2024-02-22
US Biogen Inc (BIIB)
S Sale
262 -5.1%
221.23
US$57,962 		262 -5.1% 221.23 US$57,962
2024-02-22 2024-02-22
US Biogen Inc (BIIB)
PrS Proposed sale
262
221.23
US$57,962 		262 221.23 US$57,962
2024-02-21 2024-02-21
US Biogen Inc (BIIB)
PrS Proposed sale
108
221.49
US$23,921 		108 221.49 US$23,921
2024-02-21 2024-02-16
US Biogen Inc (BIIB)
S Sale
108 -2.1%
221.49
US$23,921 		108 -2.1% 221.49 US$23,921
2024-02-13 2024-02-12
US Biogen Inc (BIIB)
S Sale
419 -8.5%
239.45
US$100,330 		419 -8.5% 239.45 US$100,330
2024-02-12 2024-02-12
US Biogen Inc (BIIB)
PrS Proposed sale
419
239.45
US$100,330 		419 239.45 US$100,330
2024-02-05 2024-02-02
US Biogen Inc (BIIB)
S Sale
634 -13.4%
245.93
US$155,920 		634 -13.4% 245.93 US$155,920
2024-02-02 2024-02-02
US Biogen Inc (BIIB)
PrS Proposed sale
634
245.93
US$155,920 		634 245.93 US$155,920
2023-12-12 2023-12-11
US Biogen Inc (BIIB)
S Sale
110 -3.1%
248.00
US$27,280 		110 -3.1% 248.00 US$27,280
2023-12-11 2023-12-11
US Biogen Inc (BIIB)
PrS Proposed sale
110
248.00
US$27,280 		110 248.00 US$27,280
2023-09-06 2023-09-05
US Biogen Inc (BIIB)
S Sale
431 -11.4%
269.43
US$116,124 		431 -11.4% 269.43 US$116,124
2023-09-05 2023-09-05
US Biogen Inc (BIIB)
PrS Proposed sale
431
269.43
US$116,124 		431 269.43 US$116,124
2023-07-05 2023-07-03
US Biogen Inc (BIIB)
S Sale
81 -2.7%
282.87
US$22,912 		81 -2.7% 282.87 US$22,912
2023-07-03 2023-07-03
US Biogen Inc (BIIB)
PrS Proposed sale
81
282.87
US$22,912 		81 282.87 US$22,912
2023-04-06 2023-04-04
US Biogen Inc (BIIB)
PlS Planned sale
91 -3.1%
277.11
US$25,217 		91 -3.1% 277.11 US$25,217
2023-04-04 2023-04-04
US Biogen Inc (BIIB)
PrS Proposed sale
91
277.11
US$25,217 		91 277.11 US$25,217
2023-03-30 2023-03-28
US Biogen Inc (BIIB)
PlS Planned sale
568 -16.7%
270.06
US$153,394 		568 -16.7% 270.06 US$153,394
2023-03-28 2023-03-28
US Biogen Inc (BIIB)
PrS Proposed sale
568
270.06
US$153,394 		568 270.06 US$153,394